Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Verrica Pharmaceuticals in the last 12 months.

Price Target: n/a

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

The average analyst rating for Verrica Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	1	1	1	1	1	0
Buy	0	0	0	0	0	0
Hold	4	4	4	4	4	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	5	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 14, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 9, 2025
Oren Livnat HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 8, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 12, 2025
Serge Belanger Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Dec 20, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

32.72M

Increased by 332.45%

from 7.57M

Revenue Next Year

36.92M

Increased by 12.85%

from 32.72M

EPS This Year

-1.30

from -14.78

EPS Next Year

-2.39

from -1.30

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	12.00M	9.03M	5.12M	7.57M	32.72M	36.92M
Revenue Growth	-	-	-24.73%	-43.27%	47.66%	332.45%	12.85%
EPS	-17.08	-13.00	-7.17	-14.78	-14.78	-1.30	-2.39
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	40.1M	47.3M
Avg	32.7M	36.9M
Low	27.4M	30.4M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	430.3%	44.4%
Avg	332.4%	12.9%
Low	262.7%	-7.1%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.85	-2.46
Avg	-1.30	-2.39
Low	-1.71	-2.30

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.